Cambridge, United Kingdom

Daniela Sydoruk

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniela Sydoruk in Antibody Development

Introduction

Daniela Sydoruk, an accomplished inventor based in Cambridge, GB, has made significant contributions to the field of biotechnology. She holds a patent that marks her innovative work in the development of PD-1 binding agents that leverage distinct mechanisms for therapeutic applications. Her efforts focus on improving disease treatment, prevention, and detection through inventive methodologies.

Latest Patents

Daniela Sydoruk has one prominent patent titled "Single domain antibodies to programmed cell death (PD-1)." This invention pertains to PD-1 binding agents that maintain the interaction of PD-1 with its ligands, offering unique potential in the therapeutic landscape. The innovative approach allows for new avenues in treating various diseases while avoiding some of the complications associated with traditional PD-1 blocking agents.

Career Highlights

Currently, Daniela is a pivotal member of Crescendo Biologics Limited, a company dedicated to creating transformative biologics. Throughout her career, she has engaged in cutting-edge research that emphasizes the importance of innovative solutions in healthcare. Her commitment to advancing scientific knowledge and applications is reflected in her pioneering patent work.

Collaborations

Daniela has collaborated with notable professionals in the field, including Bryan Edwards and Carolyn Edwards. Their combined expertise and insight further bolster the impact of their collective work, aiming to enhance therapeutic strategies and contribute meaningfully to medical advancements.

Conclusion

Daniela Sydoruk exemplifies the spirit of innovation in biotechnology with her groundbreaking work on PD-1 binding agents. As she continues her work at Crescendo Biologics Limited in collaboration with esteemed colleagues, she remains a vital force in the pursuit of novel treatments and disease management strategies. Her contributions are a testament to the potential of inventive solutions in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…